126 related articles for article (PubMed ID: 12051640)
1. Detection of numerical chromosomal abnormalities in epithelial ovarian neoplasms by fluorescence in situ hybridization (FISH) and a review of the current literature.
Huang NF; Gupta M; Varghese S; Rao S; Luke S
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):187-93. PubMed ID: 12051640
[TBL] [Abstract][Full Text] [Related]
2. Interphase cytogenetic analysis of mucinous ovarian neoplasms.
Diebold J; Siegert S; Baretton GB; Suchy B; Meier W; Haas CJ; Löhrs U
Lab Invest; 1997 May; 76(5):661-70. PubMed ID: 9166285
[TBL] [Abstract][Full Text] [Related]
3. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
Evans MF; McDicken IW; Herrington CS
J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
[TBL] [Abstract][Full Text] [Related]
4. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.
Diebold J; Deisenhofer I; Baretton GB; Blasenbreu S; Suchy B; Schneiderbanger K; Meier W; Haas CJ; Löhrs U
Lab Invest; 1996 Oct; 75(4):473-85. PubMed ID: 8874380
[TBL] [Abstract][Full Text] [Related]
5. Genomic imbalances in ovarian borderline serous and mucinous tumors.
Hu J; Khanna V; Jones MM; Surti U
Cancer Genet Cytogenet; 2002 Nov; 139(1):18-23. PubMed ID: 12547152
[TBL] [Abstract][Full Text] [Related]
6. Frequent loss of chromosome 12 in human epithelial ovarian tumors: a chromosomal in situ hybridization study.
Tanyi J; Tory K; Amo-Takyi BK; Füzesi L
Int J Gynecol Pathol; 1998 Apr; 17(2):106-12. PubMed ID: 9553805
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.
Hauptmann S; Denkert C; Koch I; Petersen S; Schlüns K; Reles A; Dietel M; Petersen I
Hum Pathol; 2002 Jun; 33(6):632-41. PubMed ID: 12152163
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
9. [The application of interphase fluorescence in situ hybridization to the diagnosis of X chromosomal count abnormality in ovarian carcinoma cell].
Liu YZ; Shuai CX; Dong JY
Yi Chuan; 2005 Mar; 27(2):185-9. PubMed ID: 15843342
[TBL] [Abstract][Full Text] [Related]
10. Allelic imbalance is not restricted to numerically abnormal chromosomes in epithelial ovarian tumours.
Evans MF; Herrington CS
J Pathol; 2001 Nov; 195(4):443-50. PubMed ID: 11745676
[TBL] [Abstract][Full Text] [Related]
11. Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways.
Körner M; Burckhardt E; Mazzucchelli L
J Pathol; 2005 Sep; 207(1):20-6. PubMed ID: 16021676
[TBL] [Abstract][Full Text] [Related]
12. Interphase fluorescence in situ hybridization studies of ovarian adenocarcinomas using the midisatellite probe.
Kalir T; Eisberg A; Dottino P; Cohen C
Gynecol Oncol; 1999 Feb; 72(2):208-14. PubMed ID: 10021303
[TBL] [Abstract][Full Text] [Related]
13. Comparative interphase cytogenetics using FISH on human ovarian carcinomas.
Liehr T; Stübinger A; Thoma K; Tulusan HA; Gebhart E
Anticancer Res; 1994; 14(1A):183-8. PubMed ID: 8166447
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms.
Tibiletti MG; Bernasconi B; Furlan D; Bressan P; Cerutti R; Facco C; Franchi M; Riva C; Cinquetti R; Capella C; Taramelli R
Clin Cancer Res; 2001 Nov; 7(11):3404-9. PubMed ID: 11705855
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization.
Wolf NG; Abdul-Karim FW; Farver C; Schröck E; du Manoir S; Schwartz S
Genes Chromosomes Cancer; 1999 Aug; 25(4):307-15. PubMed ID: 10398423
[TBL] [Abstract][Full Text] [Related]
16. Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67.
Kohlberger PD; Kieback DG; Mian C; Wiener H; Kainz C; Gitsch G; Breitenecker G
J Soc Gynecol Investig; 1997; 4(5):262-4. PubMed ID: 9360232
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors.
Persons DL; Hartmann LC; Herath JF; Keeney GL; Jenkins RB
Am J Clin Pathol; 1994 Dec; 102(6):775-9. PubMed ID: 7801890
[TBL] [Abstract][Full Text] [Related]
18. An approach for quantitative assessment of fluorescence in situ hybridization (FISH) signals for applied human molecular cytogenetics.
Iourov IY; Soloviev IV; Vorsanova SG; Monakhov VV; Yurov YB
J Histochem Cytochem; 2005 Mar; 53(3):401-8. PubMed ID: 15750029
[TBL] [Abstract][Full Text] [Related]
19. Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.
Persons DL; Hartmann LC; Herath JF; Borell TJ; Cliby WA; Keeney GL; Jenkins RB
Am J Pathol; 1993 Mar; 142(3):733-41. PubMed ID: 8096121
[TBL] [Abstract][Full Text] [Related]
20. Detection of numerical chromosome anomalies in interphase cells of ovarian carcinomas using fluorescence in situ hybridization.
Brock JA; Liu WH; Smith ST; Young SR
Genes Chromosomes Cancer; 1996 Jun; 16(2):120-9. PubMed ID: 8818659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
